Headlands Technologies »

Merrimack Pharma shares owned by Headlands Technologies

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0k 300 13.41

More positions owned by Headlands Technologies

Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Pepsi (PEP)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Workday Cl A (WDAY)
Citigroup Com New (C)
Icici Bank Adr (IBN)
Synopsys (SNPS)
Meta Platforms Cl A (META)

View all positions for Headlands Technologies

Top funds holding Merrimack Pharma

Western Standard
Newtyn Management
Vanguard Group
Madison Avenue Partners
ADAR1 Capital Management
Dimensional Fund Advisors
Sepio Capital
Indaba Capital Management
Wittenberg Investment Management
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management

View all funds holding Merrimack Pharma